CSIMarket
 
Mbx Biosciences Inc   (NASDAQ: MBX)
 

Mbx Biosciences Inc's Customers Performance

MBX



 
MBX's Source of Revenues

• List of MBX Customers




for the same period Mbx Biosciences Inc

• List of MBX Customers





Mbx Biosciences Inc's Comment on Sales, Marketing and Customers



The company operates within a regulatory environment governed by federal healthcare laws and regulations, including the Anti-Kickback Statute, the False Claims Act (FCA), and the Health Insurance Portability and Accountability Act of 1996 (HIPAA). These laws pertain to healthcare programs such as Medicare and Medicaid and address matters related to fraud, abuse, false claims, and privacy in healthcare transactions.


  News about Mbx Biosciences Inc Contracts

MBX 2109 Phase 2 Avail Hypoparathyroidism Trial Rationale and Design Presented at ASBMR 2024

In a significant development for the treatment of hypoparathyroidism (HP), MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company, presented compelling data concerning the rationale and design of its Phase 2 Avail trial for the investigational drug MBX 2109. The presentation was featured at the American Society for Bone and Mineral Research (ASBMR) 2024 Annual Meeting, held from September 27-30, 2024, in Toronto, Ontario, Canada.Hypoparathyroidism is an endocrine disorder characterized by deficient production of parathyroid hormone (PTH), leading to hypocalcemia and resulting in a range of symptoms, including muscle cramps, tingling, and potentially severe complications such as seizu...




Mbx Biosciences Inc’s Comment on Sales, Marketing and Customers


The company operates within a regulatory environment governed by federal healthcare laws and regulations, including the Anti-Kickback Statute, the False Claims Act (FCA), and the Health Insurance Portability and Accountability Act of 1996 (HIPAA). These laws pertain to healthcare programs such as Medicare and Medicaid and address matters related to fraud, abuse, false claims, and privacy in healthcare transactions.








MBX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Mbx Biosciences Inc 2,754.46 0.00 -104.29 63
SUBTOTAL 0.00 0.00 0.00 -

Sources: Mbx Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Mbx Biosciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Mbx Biosciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.